Filing Details

Accession Number:
0001472157-13-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-04 12:43:34
Reporting Period:
2013-01-04
Filing Date:
2013-01-04
Accepted Time:
2013-01-04 12:43:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1285819 Omeros Corp OMER Pharmaceutical Preparations (2834) 911663741
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472157 Ray Aspiri 201 Elliott Avenue West
Seattle WA 98119
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-04 40,000 $5.72 186,872 No 4 P Indirect By Aspiri Enterprises LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Aspiri Enterprises LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,306 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $5.66 to $5.83; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  2. The reporting person is the managing partner and a member of Aspiri Enterprises LLC, the owner of the securities.